Form D · Biotechnology
Xyone Therapeutics, Inc.
Weston, MA · CIK 0001889232
Offering snapshot reported Oct 28, 2021 · SEC filing
- Reported sold
- Yet to sell Offering amount: $7.5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $250 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 28, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-418935
Source: Form D, filed Oct 28, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anshuman Goyal | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
200 South Ave
Weston, MA, 02493
Weston, MA, 02493